FLJ36070 (MEF2 activating motif and SAP domain containing transcriptional regulator) Blocking Peptide (the N terminal of FLJ36070)(100ug)

Supplier: Aviva Systems Biology Incorporated

0 reviews | Write a Review Pencil

Description
Additional Information

This is a synthetic peptide designed for use in combination with anti-FLJ36070 Antibody(ARP55828_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

Reactivities:	Human
Presku:	AAP55828
Size:	100ug
Weight:	33kDa
Gene:	284358
Format:	Lyophilized powder
Target:	FLJ36070 is a transcriptional coactivator.FLJ36070 stimulates the transcriptional activity of MEF2C. FLJ36070 stimulates MYOD1 activity in part via MEF2, resulting in an enhancement of skeletal muscle differentiation.
Alternative names:	FLJ36070; MASTR; MGC117259